Patent · US Active

Compounds useful as Raf kinase inhibitors

US8293752B2 · kind B2 · utility

4Cited by
17References
13Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 30, 2008
Grant dateOct 23, 2012
Priority date
Expiry dateAug 4, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/65583
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds useful as inhibitors of Raf protein kinase. The present invention also provides compositions thereof, and methods of treating Raf-mediated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.